News | November 01, 2021
GlaxoSmithKline posts Q2FY22 consolidated PAT at Rs. 204.24 Cr
GlaxoSmithKline Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021
GlaxoSmithKline Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021
Dr. Reddy's Laboratories has reported consolidated financial results for the period ended September 30, 2021
These modules will act as a guide to doctors and health care workers to deal with post-Covid-19 issues
PPH is associated with almost 20 per cent of maternal mortality in India
The sales of vaccines have registered a growth of 41% in Q1 FY22, and the sale of health products have registered a growth of 94% in Q1 FY22.
The profits were bolstered by the Boehringer Ingelheim MEK program income
India business contributes to a stellar performance
Forex gains stood at Rs 20 crore for the quarter
This robust growth has come despite the raging pandemic for most part of the quarter
EPS climbs to Rs 9.25 for the quarter
Subscribe To Our Newsletter & Stay Updated
